261 related articles for article (PubMed ID: 9492352)
21. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.
Setchell KD; Zimmer-Nechemias L; Cai J; Heubi JE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1453S-1461S. PubMed ID: 9848516
[TBL] [Abstract][Full Text] [Related]
22. Tofu and soy drinks contain phytoestrogens.
Dwyer JT; Goldin BR; Saul N; Gualtieri L; Barakat S; Adlercreutz H
J Am Diet Assoc; 1994 Jul; 94(7):739-43. PubMed ID: 8021414
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.
Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S
Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892
[TBL] [Abstract][Full Text] [Related]
24. Phyto-oestrogens in soy-based infant formula.
Huggett AC; Pridmore S; Malnoë A; Haschke F; Offord EA
Lancet; 1997 Sep; 350(9080):815-6. PubMed ID: 9298031
[No Abstract] [Full Text] [Related]
25. Soy isoflavones: a safety review.
Munro IC; Harwood M; Hlywka JJ; Stephen AM; Doull J; Flamm WG; Adlercreutz H
Nutr Rev; 2003 Jan; 61(1):1-33. PubMed ID: 12638461
[TBL] [Abstract][Full Text] [Related]
26. Soy isoflavones as safe functional ingredients.
Song WO; Chun OK; Hwang I; Shin HS; Kim BG; Kim KS; Lee SY; Shin D; Lee SG
J Med Food; 2007 Dec; 10(4):571-80. PubMed ID: 18158825
[TBL] [Abstract][Full Text] [Related]
27. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet.
Pollard M; Wolter W
Prostate; 2000 Oct; 45(2):101-5. PubMed ID: 11027408
[TBL] [Abstract][Full Text] [Related]
28. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.
Irvine CH; Shand N; Fitzpatrick MG; Alexander SL
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1462S-1465S. PubMed ID: 9848517
[TBL] [Abstract][Full Text] [Related]
29. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood.
Strom BL; Schinnar R; Ziegler EE; Barnhart KT; Sammel MD; Macones GA; Stallings VA; Drulis JM; Nelson SE; Hanson SA
JAMA; 2001 Aug; 286(7):807-14. PubMed ID: 11497534
[TBL] [Abstract][Full Text] [Related]
30. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of serotonin re-uptake by licorice constituents.
Ofir R; Tamir S; Khatib S; Vaya J
J Mol Neurosci; 2003 Apr; 20(2):135-40. PubMed ID: 12794307
[TBL] [Abstract][Full Text] [Related]
32. Phytoestrogens: the "natural" selective estrogen receptor modulators?
Brzezinski A; Debi A
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):47-51. PubMed ID: 10428321
[TBL] [Abstract][Full Text] [Related]
33. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance.
Tikkanen MJ; Wähälä K; Ojala S; Vihma V; Adlercreutz H
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3106-10. PubMed ID: 9501223
[TBL] [Abstract][Full Text] [Related]
34. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.
Wiseman H; O'Reilly JD; Adlercreutz H; Mallet AI; Bowey EA; Rowland IR; Sanders TA
Am J Clin Nutr; 2000 Aug; 72(2):395-400. PubMed ID: 10919933
[TBL] [Abstract][Full Text] [Related]
35. Natural and synthetic isoflavones in the prevention and treatment of chronic diseases.
Brandi ML
Calcif Tissue Int; 1997; 61 Suppl 1():S5-8. PubMed ID: 9263608
[TBL] [Abstract][Full Text] [Related]
36. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.
Sirtori CR
Drug Saf; 2001; 24(9):665-82. PubMed ID: 11522120
[TBL] [Abstract][Full Text] [Related]
37. Potential risks and benefits of phytoestrogen-rich diets.
Cassidy A
Int J Vitam Nutr Res; 2003 Mar; 73(2):120-6. PubMed ID: 12747219
[TBL] [Abstract][Full Text] [Related]
38. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women.
Xu X; Duncan AM; Merz BE; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1101-8. PubMed ID: 9865428
[TBL] [Abstract][Full Text] [Related]
39. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast.
Hargreaves DF; Potten CS; Harding C; Shaw LE; Morton MS; Roberts SA; Howell A; Bundred NJ
J Clin Endocrinol Metab; 1999 Nov; 84(11):4017-24. PubMed ID: 10566643
[TBL] [Abstract][Full Text] [Related]
40. A model to estimate the oestrogen receptor mediated effects from exposure to soy isoflavones in food.
Safford B; Dickens A; Halleron N; Briggs D; Carthew P; Baker V
Regul Toxicol Pharmacol; 2003 Oct; 38(2):196-209. PubMed ID: 14550760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
